Lupin gets USFDA EIR for Aurangabad Facility Medical Dialogues Bureau4 April 2020 1:38 PM ISTMumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its...
Sreeji Gopinathan joins Lupin as Chief Information Officer Medical Dialogues Bureau3 Oct 2019 4:03 PM ISTMumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will...
Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad Medical Dialogues Bureau5 Aug 2019 9:45 AM ISTLupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US...
Lupin to focus on launch of biosimilar, inhalation product in US this fiscal Medical Dialogues Bureau15 July 2019 9:45 AM ISTCoupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they...
Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug Medical Dialogues Bureau24 Dec 2018 9:30 AM ISTMumbai: Pharma major Lupin and global biopharmaceutical company AbbVie Inc., announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated...
Lupin gets warning letter from USFDA for Goa, Indore plants Ruby Khatun Khatun17 Nov 2017 11:00 AM ISTNew Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms...
Pharma Doyen, Lupin founder passes away Ruby Khatun Khatun27 Jun 2017 3:03 PM ISTMumbai: Dr Desh Bandhu Gupta, Founder and Chairman of Lupin Limited (Lupin), passed away early this morning in Mumbai. He was 79 years old. He will be...
